Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 5/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | ESR1 | P03372 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 8/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5151121 | 0.91 | STS (0.53) | STSMAPTCYP3A4ESR1TP53 | |
| SCHEMBL5149396 | 0.88 | CA2 (0.63) | STSMAPTCYP3A4ESR1TP53 | |
| SCHEMBL3867766 | 0.85 | STS (0.56) | STSMAPTCYP3A4ESR1TP53 | |
| SCHEMBL3865655 | 0.85 | CA2 (0.64) | STSMAPTCYP3A4ESR1TP53 | |
| SCHEMBL3864711 | 0.84 | CA2 (0.56) | STSMAPTCYP3A4ESR1TP53 | |
| SCHEMBL3866231 | 0.84 | CA2 (0.56) | STSMAPTCYP3A4ESR1TP53 | |
| SCHEMBL3866820 | 0.84 | ESR1 (0.56) | STSMAPTCYP3A4ESR1TP53 | |
| SCHEMBL3870706 | 0.83 | CA2 (0.58) | STSMAPTCYP3A4ESR1TP53 | |
| SCHEMBL3866484 | 0.83 | STS (0.54) | STSMAPTCYP3A4ESR1TP53 | |
| SCHEMBL3866406 | 0.83 | ESR1 (0.54) | STSMAPTCYP3A4ESR1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070135399-A1 | Heteroaromatic sulphonamide prodrugs | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135399-A1 | Heteroaromatic sulphonamide prodrugs | SULT2A1, SULT1E1, SULT1A1 | STS 4/4885MAPT 4336/4885CYP3A4 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.